cancerconsultants.com
08-Jul-2008
Therapy delivered to cancer patients by oncology nurses improves cancer-related depression compared with standard therapies. These results were recently published in the Lancet. ODAC Recommends Approval of Nplate (07/07/2008) The Oncology Drugs Advisory Committee (ODAC), which provides recommendations to the U.S. Food and Drug Administration (FDA), has recommended the approval of Nplate™ (romiplostim) for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP). Measuring EGFR from Cancer Cells in Blood Can Monitor Treatment Effectiveness in Lung Cancer (07/07/2008) Measuring changes in cancer cells through a microchip from blood samples may provide a way to monitor treatment effectiveness among patients with advanced non–small cell lung cancer (NSCLC). These results...
[read full story]